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Nontuberculous mycobacteria (NTM) are a diverse group of bacterial species that are dis-
tributed in the environment. Many of these environmental bacteria can cause disease in
humans. The identification of NTM in environmental sources is important for both clinical
and epidemiological purposes. In this study, the distribution of NTM species from environ-
mental and clinical samples in the Middle East was reviewed. In order to provide an over-
view of NTM, as well as recent epidemiological trends, all studies addressing NTM in the
Middle East from 1984 to 2014 were reviewed.
A total of 96 articles were found, in which 1751 NTM strains were isolated and 1084 of
which were obtained from clinical samples, 619 from environmental samples and 48 were
cited by case reports.
Mycobacterium fortuitumwas themost common rapid growingmycobacteria (RGM) isolated
fromboth clinical (269 out of 447 RGM; 60.1%) and environmental (135 out of 289 RGM; 46.7%)
samples.Mycobacterium avium complex (MAC) was themost common slow growingmycobac-
teria (SGM) isolated from clinical samples (140 out of 637 SGM; 21.9%). An increasing trend in
NTM isolation from the Middle East was noted over the last 5 years. This review demon-
strates the increasing concern regarding NTM disease in the Middle East, emphasizing the
need for regional collaboration and coordination in order to respond appropriately.
 2015 Asian African Society for Mycobacteriology. Published by Elsevier Ltd. All rights
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a diverse group of organisms that are ubiquitous in environ-
mental sources [1]. In most regions of the world, NTM are
not reportable public health diseases, so epidemiological data
are not easily available [2]. However, data in published studies
note increasing trends in the rate of NTM isolation from dif-
ferent geographic regions in the world. Increasing NTM isola-
tion may have important public health implications [3].
Exposure to these organisms can cause serious infections in
both immunocompetent and immunocompromised individu-
als [4]. According to the latest report released by WHO, about
35.3 million people in the world are living with HIV/AIDS,
which represents one of the most vulnerable populations to
NTM infection, as well as a higher risk for complications
and poor disease outcomes [5]. Those receiving immunosup-
pressive therapy secondary to organ transplantation, cancer,
autoimmune disease and those with diabetes mellitus may
also be more susceptible to NTM as compared with the gen-
eral population, as well as suffer more severe diseases. The
incidence of NTM infections is growing all over the world.
Although countries in the Middle East have increasingly
reported NTM diseases [6], no comprehensive study of NTM
distribution has been conducted in this region. The purpose
of this review is to piece together clinical and environmental
NTM data reported in peer-reviewed published literature in
Middle Eastern countries over the last 30 years.
Methods
Literature search strategy
This study was conducted by reviewing published literature
from the Middle East using PubMed and Scopus for NTM dur-
ing the study period 1984–2014 using search terms ‘‘atypical
mycobacteria’’ [MeSH] AND ‘‘Middle East’’ [MeSH] OR ‘‘nontu-
berculous mycobacteria’’ [MeSH] AND ‘‘Middle East’’ [MeSH]
OR ‘‘environmental mycobacteria’’ [MeSH] AND ‘‘Middle East’’
[MeSH].
Inclusion and exclusion criteria
Original articles that presented cross-sectional or cohort
studies and reported the incidence of NTM in the Middle Eaststandard methods were excluded.
Data extraction and definitions
For all studies, the following data were extracted: year of pub-
lication, study setting, studies enroll time, and number of
patients investigated. Inconsistencies between the reviewers
were discussed to obtain consensus.
Data collection
The present study search strategy aimed to identify all avail-
able published studies that reported data on the incidence of
NTM in the Middle East. A total of 379 articles were identified.
Although 298 irrelevant subjects were excluded, after full
text evaluation, 96 papers (original and case report articles)
describing the incidence of NTM in the Middle East countries
were selected for analysis.
Countries included in the study
Countries were divided in two groups: Middle East countries
and Eastern neighbors of Iran (Afghanistan, Pakistan). Data
were provided from 11 countries, including Iran (34 articles)
[7–40], Turkey (21 articles) [41–61], Saudi Arabia (18 articles)
[62–79], Lebanon (5 articles) [80–84], Qatar (4 articles) [85–88],
Pakistan (4 articles) [89–92], Iraq (3 articles) [93–95], Egypt
(2 articles) [96,97], Bahrain (2 articles) [98,99], Kuwait (2 article)
[100,101], andOman (1 article) [102]. NoNTMdatawas reported
in the remaining Middle Eastern countries, including Jordan,
the United Arab Emirates, Syria, Yemen and Afghanistan.Results
Out of the 96 articles identified in the search, 48 were original
articles and the remaining were case reports. From 48 original
articles, 20 studies were conducted in Iran and 13 in Turkey.
The remaining reports were obtained from Pakistan (3), Leba-
non (3), Saudi Arabia (3), Iraq (3), Egypt (1), Kuwait (1) and
Oman (1).
In total, 1751 NTM strains were isolated from the original
studies and case reports during the study period. Among
the 1751 NTM isolates, 1084 were obtained from clinical
Table 1 – Species distribution of clinical NTM isolated in articles reported from the Middle East.
Species Iran Turkey Pakistan Lebanon Saudi Arabia Egypt Kuwait Oman Total
M. avium complex 25 54 15 17 18 2 9 140
M. fortuitum 136 48 23 1 49 5 7 269
M. simiae 103 6 1 1 1 112
M. kansasii 57 18 16 7 2 1 1 102
M. gordonae 41 53 7 1 102
M. xenopi 7 22 4 33
M. abscessus 17 45 29 2 93
M. haemophilum 2 2
M. marinum 4 1 1 22 1 39 1 69
M. chelonae 32 9 2 8 1 1 53
M. scrofulaceum 8 8 2 2 20
M. lentiflavum 4 11 2 17
M. thermoresistible 4 12 16
M. smegmatis 1 12 4 17
M. szulgai 3 9 1 13
M. mucogenicum 1 12 13
M. peregrinum 5 5
M. terrae 1 1 2 4
M. flavescens 1 2 1 4
Total 434 280 116 43 137 47 14 13 1084
Table 2 – The most frequently clinical NTM species in articles of the Middle East.
Country The most prevalent NTM 1980–1990 1990–2000 P2000 Source
Egypt M. marinum * Extra pulmonary
Kuwait M. fortuitum * Pulmonary and extra pulmonary
Pakistan M. fortuitum * Pulmonary and extra pulmonary
Pakistan M. xenopi * Pulmonary
Pakistan M. scrofulaceum * Pulmonary
Lebanon M. marinum * Extra pulmonary
Lebanon M. marinum * Extra pulmonary
Lebanon MAC * Pulmonary
Turkey M. gordonae * Pulmonary
Turkey M. gordonae * Pulmonary and extra pulmonary
Turkey M. gordonae * Pulmonary
Turkey M. abscessus * Pulmonary and extra pulmonary
Turkey M. intracellulare * Pulmonary and extra pulmonary
Turkey M. xenopi * Pulmonary
Turkey M. fortuitum * Pulmonary and extra pulmonary
Turkey M. kansasii * Extra pulmonary
Turkey M. scrofulaceum * Pulmonary
Oman MAC * Pulmonary and extra pulmonary
Saudi Arabia M. abscessus * Pulmonary and extra pulmonary
Saudi Arabia M. fortuitum * Pulmonary and extra pulmonary
Iran M. chelonae * Extra pulmonary
Iran M. fortuitum * Pulmonary and extra pulmonary
Iran M. fortuitum * Pulmonary and extra pulmonary
Iran M. fortuitum * Pulmonary
Iran M. fortuitum * Pulmonary and extra pulmonary
Iran M. kansasii * Pulmonary and extra pulmonary
Iran M. kansasii * Pulmonary
Iran M. simiae * Pulmonary and extra pulmonary
Iran M. simiae * Pulmonary and extra pulmonary
Iran M. simiae * Pulmonary and extra pulmonary
Iran M. fortuitum * Pulmonary
Iran M. intracellulare * Pulmonary
Iran M. simiae * Pulmonary and extra pulmonary
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by case reports. The majority of NTM strains were isolated
from respiratory specimens, followed by skin lesions, urogen-
ital and cerebrospinal fluid. According to included studies,
identification of NTM by conventional techniques were the
most frequently used methods.
NTM in clinical samples
Out of the 1084 isolated strains from the clinical original stud-
ies, 434 (40.0%) were reported from Iran, 280 (25.8%) from Tur-
key, 137 (12.6%) from Saudi Arabia, 116 (10.7%) from Pakistan,
47 (4.3%) from Egypt, 43 (3.9%) from Lebanon, 14 (1.2%) from
Kuwait and 13 (1.1%) from Oman (Table 1). Among the 1084
NTM isolates from clinical samples, 637 (58.7%) were catego-
rized as slow growing mycobacterium (SGM) and 447 (41.2%)
were rapidly growing mycobacterium (RGM). The most com-
mon SGM in clinical samples was Mycobacterium avium com-
plex (MAC) (140 out of 637; 21.9%). The SGM were found in
245 (56.4%) out of 434 NTM isolates of clinical samples from
Iran, 177 (63.2%) out of 280 NTM isolates from Turkey, 47
(34.3%) out of 137 NTM isolates from Saudi Arabia and 69
(59.4%) out of 116 NTM isolates from Pakistan.
The most common RGM isolated from clinical samples
was Mycobacterium fortuitum (269 out of 447 RGM; 60.1%). M.
fortuitum was found in 136 (71.9%) out of 189 RGM isolates
from Iran, 49 (54.4%) out of 90 from Saudi Arabia, 48 (46.6%)
out of 103 from Turkey, and 23 (48.9%) out of 47 from Pakistan.
The species of the most common NTM isolates, the source of
isolation and the country of origin are shown in Table 2.
NTM in environmental samples
A total of 619 environmental NTM isolates were reported from
studies from the Middle East in the last 30 years. Of these iso-
lates, 330 (53.3%) NTM species were SGM and 289 (46.6%) wereTable 3 – Species distribution of environmental NTM in articles
Species Iran Iraq
M. fortuitum 93 37
M. chelonae 38 50
M. avium complex 7 40
M. flavescens 44
M. kansasii 3 30
M. abscessus 6 33
M. gordonae 11
M. terrae 21
M. thermoresistible 24
M. xenopi 8 16
M. simiae 20
M. szulgai 19
M. lentiflavum
M. marinum 2 15
M. peregrinum 14
M. malmoense 11
M. genevense
M. haemophilum
Total 271 271RGM. Out of 619, 271 (43.7%) isolates were reported from Iran,
271 (43.7%) from Iraq, 62 (10.0%) from Turkey and 15 (2.4%)
from Saudi Arabia (Table 3).
The most common SGM by country was as follows: Myco-
bacterium flavescens in Iran (44 out of 271 SGM; 16.2%), Myco-
bacterium lentiflavum in Turkey (20 out of 62 SGM; 32.2%) and
MAC in Iraq (40 out of 271 SGM; 14.7%) (Table 3).
A total of 289 NTM isolates were considered belonging to
RGM. The most common RGM isolated from environmental
samples was M. fortuitum (135; 46.7%), followed by Mycobacte-
rium chelonae (91; 31.4%) and Mycobacterium abscessus (39;
13.4%).
As shown in Table 4, the most common NTM isolated from
soil and water samples was M. fortuitum. Table 5 shows the
frequency of the most RGM and SGM in different countries.
There was no information available regarding environmental
NTM from Israel, Pakistan, Egypt and Lebanon.
Case report
A total of 48 case reports of NTM were published from Middle
Eastern countries, including 15 (31.2%) from Saudi Arabia, 14
(29.1%) from Iran, 8 (16.6%) from Turkey, 4 (8.3%) from Qatar,
and the remaining from Lebanon, Bahrain, Pakistan, Kuwait
and Egypt (Table 6). The case reports were published during
the study period beginning in the year 2000 through 2014.
The isolated NTM species and infected organs in the case
report articles are shown in Table 6.
Trends of NTM isolates
Together, 1751 NTM isolates were reported in the Middle East,
including 1084 isolates from clinical samples, 619 from envi-
ronmental samples and 48 from the case reports. The highest
number of NTMwas isolated from Iran and Turkey. The distri-
bution of published clinical and environmental data is shownreported from the Middle East.
Turkey Saudi Arabia Total
2 3 135
3 91
2 49
44
5 2 40
39
10 8 29
6 27
24
24
2 22
2 21
20 20
17
3 17
11
6 6
3 3
62 15 619
Table 4 – The predominant NTM species found in environmental specimens.
Country The most prevalent NTM 1990–2000 P2000 Source
Iraq MAC * Milk powder
Iraq M. chelonae * Drinking water
Iraq MAC * Horse fecal
Turkey M. genevense * Raw milk
Turkey M. lentiflavum * Water
Turkey M. chelonae, M. fortuitum * Water–Soil
Turkey M. terrae * Raw milk
Saudi Arabia M. gordonae * Tap water
Iran M. fortuitum * Water
Iran M. fortuitum * Water
Iran M. fortuitum * Water–SOIL
Iran M. fortuitum * Soil
Iran M. terrae * Soil
Iran M. fortuitum * Water
Iran M. fortuitum * Water–Soil
Table 5 – The most RGM and SGM in the Middle East countries.
Country RGM SGM
Environmental Clinical Environmental Clinical
Turkey M. fortuitum 2/5 (40.0%) M. fortuitum 48/103 (46.6%) M. lentiflavum 20/57 (35.0%) M. avium complex 54/177
(30.5%)
Iran M. fortuitum 93/161 (57.7%) M. fortuitum 136/189 (71.9%) M. flavescens 44/110 (40.0%) M. simiae 103/245 (40.0%)
Saudi
Arabia
M. fortuitum 3/3 (100.0%) M. fortuitum 49/90 (54.4%) M. gordonae 8/12 (66.6%) M. avium complex 18/47
(38.2%)
Iraq M. chelonae 50/120 (41.6%) – M. avium complex
40/151 (26.4%)
–
Pakistan – M. fortuitum 23/47 (48.9%) – M. xenopi 22/69 (31.8%)
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trend in the number of NTM from clinical samples. Before
2000, less than 100 NTM isolates were reported from the Mid-
dle East countries. In the following years, the total number of
NTM isolates increased rapidly in this region, showing a rise
in the number of NTM reports.
Discussion
NTM infections are an increasing public health problem in
many countries in the world. These environmental bacteria
are capable of causing serious illnesses in both immunocom-
petent and immunocompromised individuals [103]. The rela-
tively few studies addressing this growing public health
problem in the Middle Eastern countries is also a concern.
Lack of awareness among physicians and microbiologists,
limited laboratory facilities and the already overwhelmed
health systems from other endemic diseases are possible
explanations for the lack of NTM data in the Middle East.
The absence of information regarding the distribution of
NTM poses significant challenges for infection control strate-
gies [104]. Therefore, understanding the trends and true prev-
alence of NTM is one of the major priorities to optimize
infection control programs and resources.
This study is the first review from the Middle Eastern
countries describing the identification of NTM species from
clinical and environmental samples. The increasing trendsof NTM prevalence are notable in this study, which has impor-
tant public health, healthcare system and policy implications
in the region. For example, the similar clinical presentation of
NTM to the well-established tuberculosis (TB) presents
unique challenges in diagnosis and management. NTM can
be easily misdiagnosed as TB and multidrug-resistant TB,
resulting in inappropriate management. Misdiagnosis and
delay in diagnosis of NTM can lead to serious morbidity and
mortality [105,106].
Different methods were used for the identification of NTM
in many countries. Most laboratories use conventional meth-
ods. In more recent reports, improved molecular methods
resulted in the ability to identify more NTM species [107].
National laboratories still need to standardize NTM protocols
for diagnostic methods and management in most Middle
Eastern countries.
Among the 1,084 NTM isolates from clinical samples in the
Middle East, 58.7% were SGM and 41.2% were RGM. MAC and
M. fortuitum were the most SGM and RGM, respectively. M. for-
tuitum is widely distributed in soil and water [108,109]. This
organism was first identified by Da Costa Cruz isolated from
a skin abscess in 1938 [110]. The clinical presentation ofM. for-
tuitum includes various clinical manifestations, including
most commonly skin and soft-tissue infections [111]. The
clinical diagnosis of RGM is difficult due to the absence of bio-
chemical features [112]. The prevalence of M. fortuitum in
European countries has been reported previously in Belgium
Table 6 – Case report articles of the Middle East countries.
Country Species 62000 year P2000 year Infected organ
Iran M. branderi * Bone marrow
M. chelonae * Sputum and cervical lymph node
M. aurum * Corneal biopsy
M. lentiflavum * Sputum
M. marinum * Papule
M. marinum * Nodule, pustule
M. marinum * Nodule
M. marinum * Lesion and pustule
M. monacense * Sputum
M. thermoresistibile * Cervical lymph node
M. europaeum * Sputum
M. arupense * Respiratory and blood
M. iranicum * Bronchoalveolar lavage/ hand wound
M. parascrofulaceum * Vaginal discharge
Egypt M. chelonae * Nodular lesion in leg
Kuwait M. abscessus * Peripheral blood and permanent catheter
Pakistan M. marinum * Multiple draining sinuses on chest and arm
Lebanon M. chelonae * Eye stromal bed
M. simiae * Cerebrospinal fluid and bronco alveolar
Turkey M. abscessus * Breast abscesses
MAC * Bone marrow
M. avium, intracellular * Skin lesion
M. smegmatis * Pulmonary discharges
M. fortuitum, chelonae complex * Lymph node
M. simiae * Pulmonary discharges and BAL
M. chelonae * Eye surgery
M. marinum * Soft tissue of wrist
Bahrain M. riyadhense * Pulmonary discharges
M. marinum * Nasal cavity
Qatar M. gordonae * Liver biopsy
M. gordonae * Urine
M. fortuitum * Myocardial abscess
M. fortuitum * Abdominal abscesses
Saudi Arabia M. chelonae * Blood, abdominal fluid
M. chelonae * Breast abscesses
M. chelonae * Pleural fluid
M. fortuitum, chelonae complex * Pulmonary discharges
M. fortuitum * Ascitic fluid
M. fortuitum * PD fluid
M. fortuitum * Mediastinal infection
M. fortuitum * Lipoid pneumonia
M. abscessus * Pulmonary discharges
M. abscessus * Peritoneal biopsy
M. abscessus * Peripheral blood and permanent catheter tip
M. abscessus * Pulmonary discharges
M. szulgai * Joint aspiration
M. marinum * Wound at elbow
M. kansasii * Appendiceal abscess
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(6.7%), France (6.5%), Germany (12.2%), Italy (2.5%), Portugal
(16.5%), Spain (10.8%), Switzerland (17.5%), Turkey (33.9%),
and the United Kingdom (6.0%) [112,113]. M. fortuitum was
the most common RGM found in Iran and Turkey [114].
According to this analysis,M. fortuitumwas the most common
species among the clinical isolates in the Middle East coun-
tries, including Iran.
SGM contain highly pathogenic species. MAC is a pathogen
that may cause pulmonary disease, particularly in elderly
women [115]. Disseminated MAC disease may occur in immu-
nocompromised patients, particularly HIV-infected persons.
It is estimated that more than 500,000 people living in theMiddle East are infected with HIV [116]. Therefore, it could
be speculated that MAC infection could increase in the Middle
East in the near future. Studies suggest that the prevalence of
MAC has increased in the United States, Europe and South
Korea [83]. Mycobacterium simiae is another SGM that lives in
the environment; tap water is thought to be the main source
of this mycobacterium [117]. M. simiae has been identified in
various countries, such as France, Germany and Thailand,
but most isolates have come from the Southern United States,
Cuba and Israel [114,118,119].
Based on this review,M. simiaewas the secondmost preva-
lent SGM in clinical samples (Table 1). The majority of M.
simiae strains were reported from Iran. Baghaei et al. recently
Fig. 1 – Distribution of published clinical and environmental data from the Middle East countries.
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tion from a national referral TB hospital.
The third most common SGM in clinical isolates in the
Middle East wasMycobacterium kansasii. Clinical and antigenic
characteristics ofM. kansasiimake it the most similar bacteria
to MTB. The geographic areas with the highest reported cases
ofM. kansasii are the central and southern states of the United
States, England, Wales and mining areas from Continental
Europe, mainly in the Czech Republic [120]. In Spain, the most
frequent NTM pulmonary disease is caused by M. kansasii.
[121].
Mycobacterium gordonae was isolated from 9.4% of clinical
samples (Table 1). The isolation of M. gordonae from environ-
mental samples suggests that it may cause colonization and
contamination of clinical samples [114,122]. True infections
with M. gordonae rarely occurs.
Mycobacterium xenopi belongs to a group of SGM that is
widely distributed in various regions of Europe and Canada,
but it is an uncommon pathogen of pulmonary disease in
Asia [123–126]. Identification of M. xenopi has increased glob-
ally during a 20-year period [127]. In the present study,M. xen-
opi was the most frequently isolated SGM from clinical
samples from Pakistan.The present review indicates that the NTM incidence is ris-
ing in most geographical areas in the Middle East. The
increasing number of NTM infections in Iraq, Saudi Arabia,
Turkey and Iran may be caused by the increasing awareness
of NTM and improvements in diagnosis methods [128]. It is
also possible that people in these countries are more suscep-
tible to NTM infection.
Regarding environmental NTM, this review revealed that
M. fortuitum (21.8%), M. chelonae (14.7%) and MAC (7.9%) were
the most common species. The rapidly growing organisms,
such as M. chelonae and M. fortuitum, are common in the envi-
ronment and in hospital settings [129–131]. RGM are extre-
mely resistant to antibiotics, antiseptics and disinfectants
and, consequently, are significant nosocomial pathogens. Sur-
gical procedures, accidental trauma or injections are also con-
sidered as risk factors for infections involving these
organisms [129].
Similar to clinical samples,M. fortuitumwas the most com-
mon species among RGM species obtained from environmen-
tal samples (Table 3). This finding strengthens the hypothesis
that M. fortuitum is transmitted from nature to humans. Con-
sequently, the probability of NTM transmission from person
to person should be questioned. Among SGM isolates, MAC
14 I n t e r n a t i o n a l J o u r n a l o f M y c o b a c t e r i o l o g y 4 ( 2 0 1 5 ) 7 –1 7was the most common and M. flavescens placed second in
environmental samples.
Conclusion
The number of NTM isolates has significantly increased in the
Middle East. There is an increasing concern about NTM dis-
ease in the Middle East, and regional collaboration and coor-
dination is needed to respond to it appropriately.
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